Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07011667
PHASE3

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Sponsor: Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term. The study has 2 parts: The first part is called 'the main study' and the second part is called 'the extension study'. In the main study participants will either get CagriSema (a study medicine) or placebo (a dummy medicine that looks like CagriSema but has no active ingredient). Which treatment participants get is decided by chance. Participants are two times more likely to get CagriSema than placebo. If participants get CagriSema in the main study, participants will continue on CagriSema in the extension study. Which dose of CagriSema participants will continue on is decided by chance. If participants get placebo in the main study, participants will get CagriSema in the extension study. Participants will take one injection of study medicine once a week. The study will last for about 3 years and 3 months.

Official title: Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c. (CagriSema s.c.) Once Weekly for Weight Management and Long-term Weight Maintenance in Participants With Obesity

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

609

Start Date

2025-06-03

Completion Date

2028-10-17

Last Updated

2025-12-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

CagriSema (Cagrilintide B and Semaglutide I)

CagriSema (Cagrilintide B and Semaglutide I) will be administered subcutaneously using DV3384 pen-injector.

DRUG

Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Placebo matched to Cagrilintide B and placebo matched to Semaglutide I will be administered subcutaneously using DV3384 pen-injector.

Locations (46)

FDRC

Costa Mesa, California, United States

Linda Vista Health Care Ctr

San Diego, California, United States

Diablo Clinical Research, Inc.

Walnut Creek, California, United States

Northeast Research Institute

Fleming Island, Florida, United States

Jacksonville Ctr For Clin Res

Jacksonville, Florida, United States

South Broward Research LLC

Miramar, Florida, United States

Florida Inst For Clin Res LLC

Orlando, Florida, United States

Oviedo Medical Research, LLC

Oviedo, Florida, United States

Cnt for Diab,Obes, and Metab

Pembroke Pines, Florida, United States

Hope Clin Res & Wellness

Conyers, Georgia, United States

Endocrine Research Solutions

Roswell, Georgia, United States

Great Lakes Clinical Trials

Chicago, Illinois, United States

Endeavor Health

Skokie, Illinois, United States

Evanston Premier Hlthcr Res

Skokie, Illinois, United States

Midwest Inst For Clin Res

Indianapolis, Indiana, United States

Iowa Diab & Endo Res Center

West Des Moines, Iowa, United States

Northern Pines Hlth Ctr, PC

Buckley, Michigan, United States

StudyMetrix Research LLC

City of Saint Peters, Missouri, United States

Amicis Centers of Clinical Research

St Louis, Missouri, United States

Mercury Str Med Grp, PLLC

Butte, Montana, United States

Southgate Medical Group, LLP

West Seneca, New York, United States

Great Lakes Medical Research

Westfield, New York, United States

University of North Carolina

Chapel Hill, North Carolina, United States

Medication Mgmnt, LLC_Grnsboro

Greensboro, North Carolina, United States

PharmQuest Life Sciences LLC

Greensboro, North Carolina, United States

Accellacare_NC

Raleigh, North Carolina, United States

Piedmont Healthcare/Research

Statesville, North Carolina, United States

Accellacare

Wilmington, North Carolina, United States

New Venture Medical Research

Wadsworth, Ohio, United States

Lynn Institute of Norman

Norman, Oklahoma, United States

Clinical Res Collaborative

Cumberland, Rhode Island, United States

Coastal Carolina Res Ctr

North Charleston, South Carolina, United States

Hillcrest Clinical Research

Simpsonville, South Carolina, United States

Spartanburg Medical Research

Spartanburg, South Carolina, United States

Holston Medical Group

Kingsport, Tennessee, United States

Clinical Research Associates

Nashville, Tennessee, United States

Amarillo Medical Specialists

Amarillo, Texas, United States

Velocity Clin Res, Dallas

Dallas, Texas, United States

PlanIt Research, PLLC

Houston, Texas, United States

Radiance Clinical Research

Lampasas, Texas, United States

DCOL Ctr for Clin Res

Longview, Texas, United States

Northeast Clinical Research of San Antonio

Schertz, Texas, United States

Washington Cntr Weight Mgmt

Arlington, Virginia, United States

Health Res of Hampton Roads

Newport News, Virginia, United States

Selma Medical Associates

Winchester, Virginia, United States

Rainier Clin Res Ctr Inc

Renton, Washington, United States